{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:34:00Z","timestamp":1648611240789},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12929-015-0124-4","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T01:21:48Z","timestamp":1427160108000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice"],"prefix":"10.1186","volume":"22","author":[{"given":"Andres F","family":"Zuluaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz E","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Vesga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"issue":"9693","key":"124_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O\u2019Brien","year":"2009","unstructured":"O\u2019Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893\u2013902.","journal-title":"Lancet"},{"issue":"16","key":"124_CR2","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.2165\/00003495-200767160-00005","volume":"67","author":"F Van Bambeke","year":"2007","unstructured":"Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs. 2007;67(16):2355\u201382.","journal-title":"Drugs"},{"issue":"10","key":"124_CR3","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1073\/pnas.1121383109","volume":"109","author":"R Malley","year":"2012","unstructured":"Malley R, Anderson PW. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc Natl Acad Sci U S A. 2012;109(10):3623\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"124_CR4","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1016\/j.vaccine.2010.04.020","volume":"28","author":"R Reinert","year":"2010","unstructured":"Reinert R, Jacobs MR, Kaplan SL. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine. 2010;28(26):4249\u201359.","journal-title":"Vaccine"},{"issue":"3","key":"124_CR5","doi-asserted-by":"publisher","first-page":"L387","DOI":"10.1152\/ajplung.00330.2007","volume":"294","author":"JP Mizgerd","year":"2008","unstructured":"Mizgerd JP, Skerrett SJ. Animal models of human pneumonia. Am J Physiol Lung Cell Mol Physiol. 2008;294(3):L387\u201398.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"124_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1128\/AAC.45.4.1078-1085.2001","volume":"45","author":"H Erlendsdottir","year":"2001","unstructured":"Erlendsdottir H, Knudsen JD, Odenholt I, Cars O, Espersen F, Frimodt-Moller N, et al. Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob Agents Chemother. 2001;45(4):1078\u201385.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"124_CR7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1128\/AAC.44.6.1575-1577.2000","volume":"44","author":"E Azoulay-Dupuis","year":"2000","unstructured":"Azoulay-Dupuis E, Rieux V, Muffat-Joly M, Bedos JP, Vallee E, Rivier C, et al. Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother. 2000;44(6):1575\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"124_CR8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/iai.65.4.1237-1244.1997","volume":"65","author":"KA Benton","year":"1997","unstructured":"Benton KA, Paton JC, Briles DE. Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect Immun. 1997;65(4):1237\u201344.","journal-title":"Infect Immun"},{"issue":"1","key":"124_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/iai.60.1.111-116.1992","volume":"60","author":"DE Briles","year":"1992","unstructured":"Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun. 1992;60(1):111\u20136.","journal-title":"Infect Immun"},{"issue":"4","key":"124_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/CMR.00012-08","volume":"21","author":"D Chiavolini","year":"2008","unstructured":"Chiavolini D, Pozzi G, Ricci S. Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev. 2008;21(4):666\u201385.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"124_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1086\/432513","volume":"192","author":"A Sandgren","year":"2005","unstructured":"Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S, Henriques-Normark B. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. J Infect Dis. 2005;192(5):791\u2013800.","journal-title":"J Infect Dis"},{"issue":"6","key":"124_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ijantimicag.2005.08.022","volume":"26","author":"E Nuermberger","year":"2005","unstructured":"Nuermberger E, Helke K, Bishai WR. Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy. Int J Antimicrob Agents. 2005;26(6):497\u2013503.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"124_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/jac\/43.3.367","volume":"43","author":"K Tateda","year":"1999","unstructured":"Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K. Efficacy of beta-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA\/J mice. J Antimicrob Chemother. 1999;43(3):367\u201371.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"124_CR14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/AAC.42.4.862","volume":"42","author":"JP Bedos","year":"1998","unstructured":"Bedos JP, Rieux V, Bauchet J, Muffat-Joly M, Carbon C, Azoulay-Dupuis E. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob Agents Chemother. 1998;42(4):862\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"124_CR15","doi-asserted-by":"publisher","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","volume":"7","author":"HB van der Worp","year":"2010","unstructured":"van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O\u2019Collins V, et al. Can animal models of disease reliably inform human studies? PLoS Med. 2010;7(3):e1000245.","journal-title":"PLoS Med"},{"issue":"6","key":"124_CR16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.40.6.1520","volume":"40","author":"K Tateda","year":"1996","unstructured":"Tateda K, Takashima K, Miyazaki H, Matsumoto T, Hatori T, Yamaguchi K. Noncompromised penicillin-resistant pneumococcal pneumonia CBA\/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob Agents Chemother. 1996;40(6):1520\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"124_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2180-5-34","volume":"5","author":"AV Restrepo","year":"2005","unstructured":"Restrepo AV, Salazar BE, Agudelo M, Rodriguez CA, Zuluaga AF, Vesga O. Optimization of culture conditions to obtain maximal growth of penicillin-resistant Streptococcus pneumoniae. BMC Microbiol. 2005;5:34.","journal-title":"BMC Microbiol"},{"issue":"2","key":"124_CR18","first-page":"115","volume":"16","author":"AF Zuluaga","year":"2003","unstructured":"Zuluaga AF, Salazar BE, Galvis W, Loaiza SA, Agudelo M, Vesga O. [Foundation of a functional murine pathogen free animal facility in Colombia]. Iatreia. 2003;16(2):115\u201331.","journal-title":"Iatreia"},{"key":"124_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2334-6-55","volume":"6","author":"AF Zuluaga","year":"2006","unstructured":"Zuluaga AF, Salazar BE, Rodriguez CA, Zapata AX, Agudelo M, Vesga O. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect Dis. 2006;6:55.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"124_CR20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/026119290102900409","volume":"29","author":"MFW Festing","year":"2001","unstructured":"Festing MFW. Guidelines for the design and statistical analysis of experiments in papers submitted. Atla-Altern Lab Anim. 2001;29(4):427\u201346.","journal-title":"Atla-Altern Lab Anim"},{"issue":"5","key":"124_CR21","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1128\/iai.60.5.1957-1962.1992","volume":"60","author":"DE Briles","year":"1992","unstructured":"Briles DE, Forman C, Crain M. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect Immun. 1992;60(5):1957\u201362.","journal-title":"Infect Immun"},{"issue":"3","key":"124_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/026119291003800309","volume":"38","author":"OE Varga","year":"2010","unstructured":"Varga OE, Hansen AK, Sandoe P, Olsson IA. Validating animal models for preclinical research: a scientific and ethical discussion. Altern Lab Anim. 2010;38(3):245\u20138.","journal-title":"Altern Lab Anim"},{"issue":"2","key":"124_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1128\/AAC.20.2.159","volume":"20","author":"G Beskid","year":"1981","unstructured":"Beskid G, Christenson JG, Cleeland R, DeLorenzo W, Trown PW. In vivo activity of ceftriaxone (Ro 13\u20139904), a new broad-spectrum semisynthetic cephalosporin. Antimicrob Agents Chemother. 1981;20(2):159\u201367.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"124_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/infdis\/163.2.319","volume":"163","author":"E Azoulay-Dupuis","year":"1991","unstructured":"Azoulay-Dupuis E, Bedos JP, Vallee E, Hardy DJ, Swanson RN, Pocidalo JJ. Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease. J Infect Dis. 1991;163(2):319\u201324.","journal-title":"J Infect Dis"},{"key":"124_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-1-60761-058-8_22","volume":"602","author":"E Medina","year":"2010","unstructured":"Medina E. Murine model of pneumococcal pneumonia. Methods Mol Biol. 2010;602:405\u201310.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"124_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijantimicag.2014.10.014","volume":"45","author":"M Agudelo","year":"2015","unstructured":"Agudelo M, Rodriguez CA, Zuluaga AF, Vesga O. Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin\/tazobactam. Int J Antimicrob Agents. 2015;45(2):161\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"124_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/01.qco.0000160901.71813.fe","volume":"18","author":"MJ Parnham","year":"2005","unstructured":"Parnham MJ. Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections. Curr Opin Infect Dis. 2005;18(2):125\u201331.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"124_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/infdis\/59.3.258","volume":"59","author":"WJ Nungester","year":"1936","unstructured":"Nungester WJ, Jourdonais LF. Mucin as an aid in the experimental production of lobar pneumonia. J Infect Dis. 1936;59(3):258\u201365.","journal-title":"J Infect Dis"},{"issue":"6","key":"124_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1084\/jem.97.6.767","volume":"97","author":"CM Macleod","year":"1953","unstructured":"Macleod CM, Krauss MR. Control by factors distinct from the S transforming principle of the amount of capsular polysaccharide produced by type III pneumococci. J Exp Med. 1953;97(6):767\u201371.","journal-title":"J Exp Med"},{"issue":"6","key":"124_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1084\/jem.86.6.439","volume":"86","author":"CM Macleod","year":"1947","unstructured":"Macleod CM, Krauss MR. Stepwise intratype transformation of pneumococcus from R to S by way of a variant intermediate in capsular polysaccharide production. J Exp Med. 1947;86(6):439\u201352.","journal-title":"J Exp Med"},{"issue":"02","key":"124_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4236\/jibtva.2012.12003","volume":"01","author":"SM Schmidt","year":"2012","unstructured":"Schmidt SM. Telavancin in experimental murine pneumococcal pneumonia. J Immune Based Ther Vaccin Antimicrob. 2012;01(02):15\u20139.","journal-title":"J Immune Based Ther Vaccin Antimicrob"},{"issue":"1\u20132","key":"124_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1025815113599","volume":"23","author":"JC Byrd","year":"2004","unstructured":"Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004;23(1\u20132):77\u201399.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"124_CR33","doi-asserted-by":"publisher","first-page":"e32418","DOI":"10.1371\/journal.pone.0032418","volume":"7","author":"B Govindarajan","year":"2012","unstructured":"Govindarajan B, Menon BB, Spurr-Michaud S, Rastogi K, Gilmore MS, Argueso P, et al. A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One. 2012;7(3):e32418.","journal-title":"PLoS One"},{"issue":"45","key":"124_CR34","doi-asserted-by":"publisher","first-page":"31751","DOI":"10.1074\/jbc.274.45.31751","volume":"274","author":"J Perez-Vilar","year":"1999","unstructured":"Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem. 1999;274(45):31751\u20134.","journal-title":"J Biol Chem"},{"issue":"3","key":"124_CR35","first-page":"501","volume":"125","author":"KB Adler","year":"1986","unstructured":"Adler KB, Hendley DD, Davis GS. Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways. Am J Pathol. 1986;125(3):501\u201314.","journal-title":"Am J Pathol"},{"issue":"2\u20133","key":"124_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cocis.2005.11.001","volume":"11","author":"R Bansil","year":"2006","unstructured":"Bansil R, Turner BS. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid In. 2006;11(2\u20133):164\u201370.","journal-title":"Curr Opin Colloid In"},{"issue":"3","key":"124_CR37","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1021\/bm0493990","volume":"6","author":"J Celli","year":"2005","unstructured":"Celli J, Gregor B, Turner B, Afdhal NH, Bansil R, Erramilli S. Viscoelastic properties and dynamics of porcine gastric mucin. Biomacromolecules. 2005;6(3):1329\u201333.","journal-title":"Biomacromolecules"},{"issue":"Pt 1","key":"124_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bj3080089","volume":"308","author":"BS Turner","year":"1995","unstructured":"Turner BS, Bhaskar KR, Hadzopoulou-Cladaras M, Specian RD, LaMont JT. Isolation and characterization of cDNA clones encoding pig gastric mucin. Biochem J. 1995;308(Pt 1):89\u201396.","journal-title":"Biochem J"},{"issue":"7","key":"124_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ajic.2011.03.013","volume":"39","author":"JE Hage","year":"2011","unstructured":"Hage JE, Petelin A, Cunha BA. Before influenza tests results are available, can droplet precautions be instituted if influenza is suggested by leukopenia, relative lymphopenia, or thrombocytopenia? Am J Infect Control. 2011;39(7):619\u201321.","journal-title":"Am J Infect Control"},{"issue":"1 Suppl","key":"124_CR40","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1097\/01.inf.0000108197.81270.35","volume":"23","author":"VT Peltola","year":"2004","unstructured":"Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23(1 Suppl):S87\u201397.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"124_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1165\/rcmb.2006-0035SF","volume":"34","author":"JA Voynow","year":"2006","unstructured":"Voynow JA, Gendler SJ, Rose MC. Regulation of mucin genes in chronic inflammatory airway diseases. Am J Respir Cell Mol Biol. 2006;34(6):661\u20135.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"124_CR42","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI115631","volume":"89","author":"US Sajjan","year":"1992","unstructured":"Sajjan US, Corey M, Karmali MA, Forstner JF. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992;89(2):648\u201356.","journal-title":"J Clin Invest"},{"issue":"2","key":"124_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1574-6968.2007.01003.x","volume":"278","author":"H Yesilkaya","year":"2008","unstructured":"Yesilkaya H, Manco S, Kadioglu A, Terra VS, Andrew PW. The ability to utilize mucin affects the regulation of virulence gene expression in Streptococcus pneumoniae. FEMS Microbiol Lett. 2008;278(2):231\u20135.","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"124_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1128\/AAC.02352-13","volume":"59","author":"CA Rodriguez","year":"2015","unstructured":"Rodriguez CA, Agudelo M, Gonzalez JM, Vesga O, Zuluaga AF. An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics. Antimicrob Agents Chemother. 2015;59(1):233\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"124_CR45","series-title":"54th Interscience Conference on Antimicrobial Agents and Chemotherapy","volume-title":"The Neutropenic Mouse Thigh Infection Model (nmtim) Without The Use Of A Foreign Body","author":"S Leiva LMI","year":"2014","unstructured":"Leiva LMI S, Gomez JP, Gonzalez M, Rodriguez CA, Agudelo M, Vesga O. Successful Growth Of Staphylococcus Epidermidis. In: The Neutropenic Mouse Thigh Infection Model (nmtim) Without The Use Of A Foreign Body, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: ASM; 2014."},{"issue":"1","key":"124_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1128\/AAC.50.1.121-125.2006","volume":"50","author":"Y Fukuda","year":"2006","unstructured":"Fukuda Y, Yanagihara K, Ohno H, Higashiyama Y, Miyazaki Y, Tsukamoto K, et al. In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model. Antimicrob Agents Chemother. 2006;50(1):121\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"124_CR47","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1128\/AAC.46.5.1425-1434.2002","volume":"46","author":"PR Tessier","year":"2002","unstructured":"Tessier PR, Kim MK, Zhou W, Xuan D, Li C, Ye M, et al. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. Antimicrob Agents Chemother. 2002;46(5):1425\u201334.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-015-0124-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-015-0124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-015-0124-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-015-0124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:49:47Z","timestamp":1630576187000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-015-0124-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1186\/s12929-015-0124-4","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]},"assertion":[{"value":"31 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}